# ArriVent BioPharma, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/arrivent-biopharma-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T04:46:18.168414+00:00 | | Last reviewed | 2026-10-16T04:46:18.168414+00:00 | ## Identity - Legal name: ArriVent BioPharma, Inc. - Display name: ArriVent BioPharma, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T09:21:34.963609+00:00 | | Completeness | 0.364 | | Record Quality | 0.83 | | Directors | 8 | | Committees | 5 | | Governance events | 12 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | NOT_REVIEWED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Carl L. Gordon, Ph.D., CFA: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:7 - Chris W. Nolet: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:8 - James Healy, M.D., Ph.D.: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:9 - John Hohneker, M.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:10 - Kristine Peterson: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:11 - Merdad Parsey, M.D., Ph.D.: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:12 - Stuart Lutzker, M.D., Ph.D.: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:13 - Zarath Summers, Ph.D.: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:14 ## Committees - Audit (audit). Chair: Chris W. Nolet. Members: Chris W. Nolet (chair, current); Kristine Peterson (member, current). committee_id=alpha:committee:arrivent-biopharma-inc:audit - Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Chris W. Nolet (member, current). committee_id=alpha:committee:arrivent-biopharma-inc:audit-chair-nominating-and-governance - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Kristine Peterson (member, current). committee_id=alpha:committee:arrivent-biopharma-inc:audit-compensation-chair - Compensation (compensation). Chair: Kristine Peterson. Members: Kristine Peterson (chair, current). committee_id=alpha:committee:arrivent-biopharma-inc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Chris W. Nolet (member, current). committee_id=alpha:committee:arrivent-biopharma-inc:nominating-and-governance ## Governance events - DIRECTOR_APPOINTED: Merdad Parsey, M.D., Ph.D. seat on ArriVent BioPharma, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:eg1xlq1c1dvyi - DIRECTOR_APPOINTED: John Hohneker, M.D. seat on ArriVent BioPharma, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:9qs3j31xyug7x - DIRECTOR_APPOINTED: Kristine Peterson seat on ArriVent BioPharma, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1enz7aa1m6jx18 - COMMITTEE_CREATED: Audit; Compensation · Chair committee of ArriVent BioPharma, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:i4taru1ebmwvg - COMMITTEE_MEMBER_ADDED: Kristine Peterson member of Audit; Compensation · Chair, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:16yeayq1bx0krw - DIRECTOR_APPOINTED: Chris W. Nolet seat on ArriVent BioPharma, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:17s3hx91n8gxuz - DIRECTOR_APPOINTED: James Healy, M.D., Ph.D. seat on ArriVent BioPharma, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:ylzy6w1vlz5y2 - COMMITTEE_CREATED: Audit · Chair; Nominating and Governance committee of ArriVent BioPharma, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1en1f711or8jcj - COMMITTEE_MEMBER_ADDED: Chris W. Nolet member of Audit · Chair; Nominating and Governance, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1j2ugkc1jkqv7k - DIRECTOR_APPOINTED: Carl L. Gordon, Ph.D., CFA seat on ArriVent BioPharma, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:13b02xjbahw6d - DIRECTOR_APPOINTED: Stuart Lutzker, M.D., Ph.D. seat on ArriVent BioPharma, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:799gpf1dtxm1b - DIRECTOR_APPOINTED: Zarath Summers, Ph.D. seat on ArriVent BioPharma, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:18f1apghzrj20 ## Scoped resources - `alpha://company/arrivent-biopharma-inc` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record - `alpha://company/arrivent-biopharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=identity - `alpha://company/arrivent-biopharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=corporate-structure - `alpha://company/arrivent-biopharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=board - `alpha://company/arrivent-biopharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=committees - `alpha://company/arrivent-biopharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=leadership - `alpha://company/arrivent-biopharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=ownership - `alpha://company/arrivent-biopharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=financials - `alpha://company/arrivent-biopharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=capital-structure - `alpha://company/arrivent-biopharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=compensation - `alpha://company/arrivent-biopharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=governance - `alpha://company/arrivent-biopharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=shareholder-governance - `alpha://company/arrivent-biopharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=audit - `alpha://company/arrivent-biopharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=legal - `alpha://company/arrivent-biopharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=risk - `alpha://company/arrivent-biopharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=cyber - `alpha://company/arrivent-biopharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=ai-governance - `alpha://company/arrivent-biopharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=agents - `alpha://company/arrivent-biopharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=ecosystem - `alpha://company/arrivent-biopharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=events - `alpha://company/arrivent-biopharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=relationships - `alpha://company/arrivent-biopharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=assessments - `alpha://company/arrivent-biopharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:chris-w-nolet","name":"Chris W. Nolet"},"source_id":"board_seats"}` - Claim alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:kristine-peterson","name":"Kristine Peterson"},"source_id":"board_seats"}` - Claim alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:kristine-peterson","name":"Kristine Peterson"},"source_id":"board_seats"}` - Claim alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:chris-w-nolet","name":"Chris W. Nolet"},"source_id":"board_seats"}` ## Leadership - Carl L. Gordon, Ph.D., CFA: Director. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:67b897a4aabce9dd7aabb21126ec50d508ce379e5e7d42b256427d0ca60dd27f. - Chris W. Nolet: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:67b897a4aabce9dd7aabb21126ec50d508ce379e5e7d42b256427d0ca60dd27f. - James Healy, M.D., Ph.D.: Director. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:9. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:67b897a4aabce9dd7aabb21126ec50d508ce379e5e7d42b256427d0ca60dd27f. - John Hohneker, M.D.: Director. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:67b897a4aabce9dd7aabb21126ec50d508ce379e5e7d42b256427d0ca60dd27f. - Kristine Peterson: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:11. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:67b897a4aabce9dd7aabb21126ec50d508ce379e5e7d42b256427d0ca60dd27f. - Merdad Parsey, M.D., Ph.D.: Director. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:12. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:67b897a4aabce9dd7aabb21126ec50d508ce379e5e7d42b256427d0ca60dd27f. - Stuart Lutzker, M.D., Ph.D.: Director. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:13. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:67b897a4aabce9dd7aabb21126ec50d508ce379e5e7d42b256427d0ca60dd27f. - Zarath Summers, Ph.D.: Director. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:leadership_role:14. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:67b897a4aabce9dd7aabb21126ec50d508ce379e5e7d42b256427d0ca60dd27f. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Chris W. Nolet; Members Chris W. Nolet (Chair); Kristine Peterson. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:55a0d6cf3c261855d6d6cede920c64fdb373e8006856730fed029e90852f5185. - Compensation: Chair Kristine Peterson; Members Kristine Peterson (Chair). Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:55a0d6cf3c261855d6d6cede920c64fdb373e8006856730fed029e90852f5185. - Nominating and Governance: Chair not stated; Members Chris W. Nolet. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:55a0d6cf3c261855d6d6cede920c64fdb373e8006856730fed029e90852f5185. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - ArriVent BioPharma, Inc.. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8c2b0d70242abb4ff5dc5d82f2edb90650a08f83a70f1c80d306532221861e0. ## Entity Status - Public listing published. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8c2b0d70242abb4ff5dc5d82f2edb90650a08f83a70f1c80d306532221861e0. ## Published Fact - US. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8c2b0d70242abb4ff5dc5d82f2edb90650a08f83a70f1c80d306532221861e0. - Healthcare. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8c2b0d70242abb4ff5dc5d82f2edb90650a08f83a70f1c80d306532221861e0. - Biotechnology. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8c2b0d70242abb4ff5dc5d82f2edb90650a08f83a70f1c80d306532221861e0. ## Committee Appointment - Chris W. Nolet: chair, Audit. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:55a0d6cf3c261855d6d6cede920c64fdb373e8006856730fed029e90852f5185. - Kristine Peterson: member, Audit. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:55a0d6cf3c261855d6d6cede920c64fdb373e8006856730fed029e90852f5185. - Kristine Peterson: chair, Compensation. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:55a0d6cf3c261855d6d6cede920c64fdb373e8006856730fed029e90852f5185. - Chris W. Nolet: member, Nominating and Governance. Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:55a0d6cf3c261855d6d6cede920c64fdb373e8006856730fed029e90852f5185. ## Security Listing - AVBP (NASDAQ). Claim: alpha:claim:company:82ea3aa3-59aa-4f9c-b2fe-30b5fd54281c:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8c2b0d70242abb4ff5dc5d82f2edb90650a08f83a70f1c80d306532221861e0. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:e8c2b0d70242abb4ff5dc5d82f2edb90650a08f83a70f1c80d306532221861e0: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/arrivent-biopharma-inc). - alpha:projection-evidence:document:67b897a4aabce9dd7aabb21126ec50d508ce379e5e7d42b256427d0ca60dd27f: [ArriVent BioPharma, Inc. DEF 14A 2025-04-28](https://www.sec.gov/Archives/edgar/data/1868279/000110465925040214/tm2513051-2_def14a.htm). - alpha:projection-evidence:55a0d6cf3c261855d6d6cede920c64fdb373e8006856730fed029e90852f5185: [Audit](https://www.sec.gov/Archives/edgar/data/1868279/000110465925040214/tm2513051-2_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/arrivent-biopharma-inc) - [Public Markdown](https://registry.alpha.ac/companies/arrivent-biopharma-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/arrivent-biopharma-inc?format=jsonld) - MCP resource: `alpha://companies/arrivent-biopharma-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T09:21:34.786862+00:00; recorded 2026-10-16T09:21:34.786862+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.